Anhui Huangshan Capsule Co Ltd Market Cap ($261.73 Million)
Market Cap & Net Worth: Anhui Huangshan Capsule Co Ltd (002817)
Anhui Huangshan Capsule Co Ltd market cap. Anhui Huangshan Capsule Co Ltd (SHE:002817) has a market capitalization of $261.73 Million (CN¥1.79 Billion) as of November 1, 2026. Listed on the SHE stock exchange, this China-based company holds position #15202 globally and #4446 in its home market, demonstrating a -3.55% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Anhui Huangshan Capsule Co Ltd's stock price CN¥5.98 by its total outstanding shares 299098170 (299.10 Million). Also see 002817 cash flow conversion for how efficiently the company converts equity into cash flow.
Anhui Huangshan Capsule Co Ltd Market Cap History (2016–2026)
Anhui Huangshan Capsule Co Ltd market cap history from 2016 to 2026. Data shows growth from $683.72 Million to $261.73 Million (0.87% CAGR). Check Anhui Huangshan Capsule Co Ltd stock quote for real-time trading data and today's change.
Anhui Huangshan Capsule Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Anhui Huangshan Capsule Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 002817 net assets growth trend to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.73x
Anhui Huangshan Capsule Co Ltd's market cap is 0.73 times its annual revenue
Latest Price to Earnings (P/E) Ratio
5.12x
Anhui Huangshan Capsule Co Ltd's market cap is 5.12 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $683.72 Million | $283.44 Million | $52.28 Million | 2.41x | 13.08x |
| 2017 | $369.66 Million | $285.96 Million | $46.42 Million | 1.29x | 7.96x |
| 2018 | $207.81 Million | $294.71 Million | $35.97 Million | 0.71x | 5.78x |
| 2019 | $274.61 Million | $325.56 Million | $39.13 Million | 0.84x | 7.02x |
| 2020 | $274.90 Million | $319.43 Million | $45.26 Million | 0.86x | 6.07x |
| 2021 | $363.77 Million | $379.89 Million | $56.89 Million | 0.96x | 6.39x |
| 2022 | $383.46 Million | $428.32 Million | $60.85 Million | 0.90x | 6.30x |
| 2023 | $377.49 Million | $462.77 Million | $64.86 Million | 0.82x | 5.82x |
| 2024 | $273.98 Million | $473.48 Million | $49.25 Million | 0.58x | 5.56x |
| 2025 | $332.63 Million | $457.84 Million | $64.99 Million | 0.73x | 5.12x |
Competitor Companies of 002817 by Market Capitalization
Companies near Anhui Huangshan Capsule Co Ltd in the global market cap rankings as of November 1, 2026. Also see Anhui Huangshan Capsule Co Ltd assets under control for a full breakdown of the balance sheet.
Key companies related to Anhui Huangshan Capsule Co Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #511 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #535 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #593 globally with a market cap of $45.23 Billion USD ( CN¥309.13 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #619 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #511 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #535 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $46.62 |
| #593 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.23 Billion | CN¥48.46 |
| #619 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.30 |
Market Capitalization of Anhui Huangshan Capsule Co Ltd (2016–2026)
Market capitalization of Anhui Huangshan Capsule Co Ltd from 2016 to today. Between 2016 and today, Anhui Huangshan Capsule Co Ltd's market cap moved from $683.72 Million to $ 261.73 Million, with a yearly change of 0.87%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥261.73 Million | -21.32% |
| 2025 | CN¥332.63 Million | +21.41% |
| 2024 | CN¥273.98 Million | -27.42% |
| 2023 | CN¥377.49 Million | -1.56% |
| 2022 | CN¥383.46 Million | +5.41% |
| 2021 | CN¥363.77 Million | +32.33% |
| 2020 | CN¥274.90 Million | +0.11% |
| 2019 | CN¥274.61 Million | +32.14% |
| 2018 | CN¥207.81 Million | -43.78% |
| 2017 | CN¥369.66 Million | -45.93% |
| 2016 | CN¥683.72 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Anhui Huangshan Capsule Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $261.73 Million USD |
| MoneyControl | $261.73 Million USD |
| MarketWatch | $261.73 Million USD |
| marketcap.company | $261.73 Million USD |
| Reuters | $261.73 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Anhui Huangshan Capsule Co Ltd
Anhui Huangshan Capsule Co., Ltd. engages in the research and development, production, and sale of gelatin and enteric-coated gelatin empty capsules in China. The company offers pullulan capsules, entersoluble vacant gelatin capsules, vacant gelatin capsules, vegetable entersoluble capsules, colonsoluble vacant gelatin capsules, hydroxypropyl methyl cellulose hollow capsules, and hydroxypropyl st… Read more